✦ LIBER ✦

Liraglutide Combined With Insulin or Oral Agents Leads to Both Improved Glycemic Control and Weight Loss in Type 2 Subjects with Diabetic Nephropathy

✍ Scribed by Vretenar, Joline; Jindal, Kailash; Senior, Peter A.

Book ID: 122654238
Publisher: Canadian Diabetes Association
Year: 2012
Tongue: English
Weight: 188 KB
Volume: 36
Category: Article
ISSN: 1499-2671
DOI: 10.1016/j.jcjd.2012.07.284

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with insulin and ora

Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus

✍ Hannele Yki-Järvinen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Empagliflozin as Add On to Basal Insulin

Empagliflozin as Add On to Basal Insulin for 78 Weeks Improves Glycemic Control with Weight Loss in Insulin-Treated Type 2 Diabetes (T2DM)

✍ Rosenstock, Julio; Jelaska, Ante; Wang, Fei; Kim, Gabriel; Broedl, Uli; Woerle, 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 51 KB

Glycemic control with an artificial panc

Glycemic control with an artificial pancreas improves insulin responses to both oral and I.V. Glucose in nonobese noninsulin-dependent diabetic subjects

✍ Giugliano, Dario ;Pinto, Paolo ;Ceriello, Antonio ;Paolisso, Giuseppe ;Saccomann 📂 Article 📅 1985 🏛 Springer-Verlag ⚖ 730 KB

Initiation of Humalog® Mix25™ therapy im

Initiation of Humalog® Mix25™ therapy improves glycemic control in patients with type 2 diabetes and inadequacy of oral agent combination therapy

✍ Matthias Herz; Scott Beattie 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Continuous subcutaneous delivery of exen

Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes

✍ Henry, Robert R.; Rosenstock, Julio; Logan, Douglas; Alessi, Thomas; Luskey, Ken 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Significantly Better Glycemic Control an

Significantly Better Glycemic Control and Weight Reduction with Liraglutide, a Once-daily Human GLP-1 Analog, Compared with Insulin Glargine: All as Add-on to Metformin and a Sulfonylurea in Type 2 Diabetes.

✍ Schmitz, O.; Russell-Jones, D.; Vaag, A.; Sethi, B.K.; lalic, N.; Antic, S.; Zdr 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 702 KB